Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study
2020 · Leukemia · 50 citations
https://doi.org/10.1038/s41375-020-0758-4
M
Marta Sobas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
151
Papers
1.3K
Citations
16
h-index
24
i10-index
Marta Sobas is an academic researcher from Medical University of Silesia. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments. The author has an h-index of 16, co-authored 129 publications.
ORCID: 0000-0003-0781-8668Papers by this author
worksAmong classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
2021 · Blood Cancer Journal · 37 citations
https://doi.org/10.1038/s41408-021-00417-3
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study
2024 · Leukemia · 25 citations
https://doi.org/10.1038/s41375-024-02333-4
Prediction of major bleeding events in 1381 patients with essential thrombocythemia
2023 · International Journal of Hematology · 7 citations
https://doi.org/10.1007/s12185-023-03650-7
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera
2025 · Leukemia · 7 citations
https://doi.org/10.1038/s41375-025-02545-2
Zaawansowana mastocytoza układowa — stanowisko ekspertów dotyczące postępowania diagnostycznego i leczniczego
2019 · Hematologia · 1 citations
https://doi.org/10.5603/hem.2019.0029
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat